Donaldson Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.39M Buy
17,167
+1,978
+13% +$277K 0.08% 100
2025
Q4
$1.86M Buy
15,189
+485
+3% +$58.9K 0.06% 107
2025
Q3
$1.63M Buy
14,704
+1,530
+12% +$174K 0.05% 118
2025
Q2
$1.46M Buy
13,174
+485
+4% +$51.6K 0.05% 120
2025
Q1
$1.42M Buy
12,689
+774
+6% +$79.9K 0.05% 118
2024
Q4
$1.1M Sell
11,915
-105
-0.9% -$9.45K 0.04% 130
2024
Q3
$1.01M Sell
12,020
-145
-1% -$11.1K 0.04% 131
2024
Q2
$835K Sell
12,165
-373
-3% -$24.9K 0.04% 133
2024
Q1
$918K Sell
12,538
-160
-1% -$12.3K 0.04% 126
2023
Q4
$1.03M Sell
12,698
-197
-2% -$15.3K 0.05% 121
2023
Q3
$966K Buy
12,895
+1,298
+11% +$99.8K 0.05% 124
2023
Q2
$894K Buy
11,597
+714
+7% +$56.9K 0.04% 130
2023
Q1
$903K Buy
10,883
+2,258
+26% +$187K 0.04% 123
2022
Q4
$740K Sell
8,625
-1,915
-18% -$152K 0.04% 135
2022
Q3
$650K Buy
10,540
+574
+6% +$36.2K 0.04% 135
2022
Q2
$616K Buy
9,966
+4,203
+73% +$260K 0.03% 141
2022
Q1
$343K Buy
5,763
+641
+13% +$41K 0.02% 214
2021
Q4
$372K Buy
5,122
+823
+19% +$56.7K 0.02% 219
2021
Q3
$300K Buy
4,299
+221
+5% +$15.5K 0.02% 224
2021
Q2
$281K Buy
4,078
+348
+9% +$23.2K 0.01% 228
2021
Q1
$241K Buy
+3,730
New +$241K 0.01% 227

Other funds holding GILD

Donaldson Capital Management's GILD Position: Q1 2026 in Review

Donaldson Capital Management increased its Gilead Sciences (GILD) stake by 13% in Q1 2026, buying an estimated $277K and bringing the position to 17,167 shares worth $2.39M. The position accounts for 0.08% of the portfolio, ranked #100.

Donaldson Capital Management first reported a position in GILD in Q1 2021 and has held it in 21 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Donaldson Capital Management held 17,167 shares of Gilead Sciences worth $2.39M as of Q1 2026.
  • Donaldson Capital Management bought 1,978 Gilead Sciences shares in Q1 2026, an estimated $277K.
  • Gilead Sciences made up 0.08% of Donaldson Capital Management's portfolio in Q1 2026, its #100 holding.
  • Donaldson Capital Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 21 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Donaldson Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.